0001209191-20-028067.txt : 20200508 0001209191-20-028067.hdr.sgml : 20200508 20200508182439 ACCESSION NUMBER: 0001209191-20-028067 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200209 FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATTERSON LEONE D CENTRAL INDEX KEY: 0001233539 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36579 FILM NUMBER: 20862142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adverum Biotechnologies, Inc. CENTRAL INDEX KEY: 0001501756 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 205258327 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-272-6269 MAIL ADDRESS: STREET 1: 800 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Avalanche Biotechnologies, Inc. DATE OF NAME CHANGE: 20100921 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2020-02-09 2020-02-10 0 0001501756 Adverum Biotechnologies, Inc. ADVM 0001233539 PATTERSON LEONE D C/O ADVERUM BIOTECHNOLOGIES, INC. 800 SAGINAW DRIVE REDWOOD CITY CA 94063 1 1 0 0 CEO, President and Director Common Stock 2020-02-09 4 F 0 10985 10.24 D 139235 D Reflects shares withheld by the Issuer upon vesting of restricted stock units to satisfy withholding tax obligations. This Form 4 Amendment is being filed solely to correct the amount of shares surrendered to satisfy a tax withholding obligation in Table I. The amount previously reflected was 11,215 shares and should have been reflected as 10,985 shares. As a result, the number of shares beneficially owned in Box 5 of Table I has been adjusted accordingly. Leone Patterson by /s/ Thomas Leung, Attorney-in-Fact. 2020-05-08